Long-term results in children with standard risk acute lymphoblastic leukaemia treated with 5.0 g/m2versus 3.0 g/m2 methotrexate i.v. according to the modified ALL-BFM 90 protocol. The report of Polish paediatric Leukemia/lymphoma study group
Titel:
Long-term results in children with standard risk acute lymphoblastic leukaemia treated with 5.0 g/m2versus 3.0 g/m2 methotrexate i.v. according to the modified ALL-BFM 90 protocol. The report of Polish paediatric Leukemia/lymphoma study group
Auteur:
Derwich, K. Wachowiak, J. Zając-Spychała, O. Balcerska, A. Balwierz, W. Chybicka, A. Kowalczyk, J. R. Matysiak, M. Jackowska, T. Sońta-Jakimczyk, D. Szczepański, T. Wysocki, M.